19th IMS Annual Meeting
AUGUST 25-27, 2022 | LOS ANGELES, CALIFORNIA
Join me at the 19th International Myeloma Society Annual Meeting!
I'm excited to speak at the 19th IMS Annual Meeting in Los Angeles, California!
Career Development Workshop, Writing successful grants
About Rafael Fonseca:
Rafael Fonseca, MD, is the Getz Family Professor of Cancer, Professor of Medicine, Chief Innovation Officer, a consultant in the Division of Hematology/Oncology at the Mayo Clinic in Arizona and a member of the Mayo Clinic Board of Governors and Board of Trustees. He earned his MD at Universidad Anahuac, Mexico. He completed a residency in internal medicine at the University of Miami, FL, and a fellowship in hematology and medical oncology at Mayo Graduate School of Medicine, Rochester, MN. He was named a clinical investigator for the Damon Runyon Cancer Research Fund. He is a visiting healthcare fellow at the Goldwater Institute. Dr Fonseca’s practice has focused on the diagnosis and treatment of plasma cell disorders and leading the multiple myeloma team in its efforts to develop a better understanding of the disease and its impact on patients. In his laboratory, Dr Fonseca has led his team of researchers regarding the genetic nature of clonal cells of plasma cell disorders, myeloma bone disease, prognostic markers, and development of new therapies for the disease. He is an active participant and leader of myeloma clinical trials. Throughout his training and career, Dr Fonseca has received numerous awards and honors, including the Damon Runyon-Walter Winchell Clinical Investigator Award, and the International Waldenström Macroglobulinemia Research Award. Most notably, he is a Mayo Clinic Distinguished Investigator, the highest academic distinction given to investigators at his institution. Dr Fonseca holds memberships and serves in positions for organizations such as the American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, and the International Myeloma Society. His research has been funded by the National Cancer Institute (R01, P01, SPORE), the Leukemia & Lymphoma Society, the Multiple Myeloma Research Fund, and the Damon Runyon Cancer Research Fund.
About Our Meeting
The International Myeloma Society Annual Meeting is the defining meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects, including:
- Scientific Programs
- Keynote Addresses
- Poster Presentations
- Oral Presentations (Basic Biology, Preclinical Trials and Clinical Studies)
Testimonials
“I’ve already come away with so many great ideas from the interactions and discussions here in Vienna. You just can’t get that any other way. It's what’s been missing for the past 2 years!”
STEVEN P. TREON, MD, PhD, FACP, FRCP
Dana Farber Cancer Institute
Boston, MA
“The 18th International Myeloma Workshop in Vienna. A milestone. Immunotherapies definitely revolutionize the treatment and challenge autologous transplantation. A very special congress I will always remember.”
LAURENT GARDERET, MD, PhD
Sorbonne Université, APHP
Paris, France
Join Us in Los Angeles
